Aggrecan Antikörper (N-Term)
Kurzübersicht für Aggrecan Antikörper (N-Term) (ABIN1731433)
Target
Alle Aggrecan (ACAN) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Reacts with Aggrecan from Human, Gorilla, Monkey, Hamster, Pig
-
Kreuzreaktivität
- Ratte (Rattus)
-
Kreuzreaktivität (Details)
- Predicted to cross react with Mouse, Rat, Bovine, Horse. BLAST analysis of the peptide immunogen showed no homology with other human proteins, except NCAN (56 % ).
-
Aufreinigung
- Antiserum
-
Immunogen
- Synthetic 18 amino acid peptide from N-terminus of human ACAN / Aggrecan. Percent identity with other species by BLAST analysis: Human, Gorilla, Monkey, Marmoset, Hamster, Pig (100%), Mouse, Rat, Bovine, Panda, Horse (94%), Dog, Elephant (89%), Bat (83%).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
IHC - P (7 μg/mL) -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-80 °C
-
Informationen zur Lagerung
- Long term: -70°C, Short term: +4°C
-
-
- Aggrecan (ACAN)
-
Andere Bezeichnung
- ACAN / Aggrecan
-
Hintergrund
- Crucial component of the extracellular matrix of cartilagenous tissue. Mutated form of Aggrecan is involved in skeletal dysplasia and spinal degeneration.
-
Gen-ID
- 176
-
Pathways
- Glycosaminoglycan Metabolic Process, Dicarboxylic Acid Transport
Target
-